Pituitary adenylate cyclase-activating polypeptide induces hyperthermia inthe rat

Citation
I. Pataki et al., Pituitary adenylate cyclase-activating polypeptide induces hyperthermia inthe rat, NEUROPHARM, 39(7), 2000, pp. 1303-1308
Citations number
33
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROPHARMACOLOGY
ISSN journal
00283908 → ACNP
Volume
39
Issue
7
Year of publication
2000
Pages
1303 - 1308
Database
ISI
SICI code
0028-3908(2000)39:7<1303:PACPIH>2.0.ZU;2-E
Abstract
The effects of centrally administered pituitary adenylate cyclase-activatin g polypeptide (PACAP-38) on body temperature were investigated in rats. Int racerebroventricular (i.c.v.) administration of PACAP-38 in doses of 500 an d 1000 ng induced a dose-related elevation in colon temperature 2, 3, 4, 5 and 6 h after injection. The i.c.v. pretreatment of the animals with differ ent dilutions of PACAP-38 antiserum prevented the development of hypertherm ia in PACAP-38-treated animals, whereas PACAP-38 antiserum alone did not mo dify the colon temperature. An intramuscular injection of noraminophenazone (a cyclooxygenase inhibitor) abolished the PACAP-38-induced hyperthermia. Our data indicate that PACAP may induce hyperthermia via the central nervou s system, and this hyperthermic effect may be mediated via a cyclooxygenase -involved pathway. (C) 2000 Elsevier Science Ltd. All rights reserved.